Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/152701
Full metadata record
DC FieldValueLanguage
dc.creatorFrancisco Coelho e Silva
dc.date.accessioned2025-11-12T17:38:44Z-
dc.date.available2025-11-12T17:38:44Z-
dc.date.issued2023-09-12
dc.date.submitted2023-07-12
dc.identifier.othersigarra:640740
dc.identifier.urihttps://hdl.handle.net/10216/152701-
dc.language.isoeng
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCiências médicas e da saúde
dc.subjectMedical and Health sciences
dc.titleThe Role of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
dc.typeDissertação
dc.contributor.uportoFaculdade de Medicina
dc.identifier.doi10.34626/sf0b-7g95
dc.identifier.tid203521366
dc.subject.fosCiências médicas e da saúde
dc.subject.fosMedical and Health sciences
thesis.degree.disciplineMestrado Integrado em Medicina
thesis.degree.grantorFaculdade de Medicina
thesis.degree.grantorUniversidade do Porto
thesis.degree.level1
Appears in Collections:FMUP - Dissertação

Files in This Item:
File Description SizeFormat 
640740.pdfThe Role of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease1.06 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons